StockData
Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc. (EVFM) stock

EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026Market cap $865.23KP/E –Yield –

Evofem Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Evofem Biosciences's enterprise value was $911.94K on Oct 19, 2026, against $765.20K a year earlier. Over the last 5 years it ranged from -$11.27M to $64.90M, with a median of $392.46K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$911.94K+45.1%
2025Dec 31, 2025$628.59K+16.6%
2024Dec 31, 2024$539.25K–
2023Dec 29, 2023-$474.45K–
2022Dec 30, 2022-$1.22M-102.8%
2021Dec 31, 2021$43.46M-60.2%
2020Dec 31, 2020$109.18M-57.4%
2019Dec 31, 2019$256.58M+166.2%
2018Dec 31, 2018$96.38M+313.6%
2017Dec 29, 2017$23.30M+1977.7%
2016Dec 30, 2016$1.12M–
2015Dec 31, 2015-$22.32M–
2014Dec 31, 2014-$493.11K–

More Evofem Biosciences figures

See a number that looks wrong?